Check-Cap (NASDAQ:CHEK) Upgraded at Zacks Investment Research
Check-Cap (NASDAQ:CHEK – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report released on Monday, Zacks.com reports. The brokerage presently has a $0.50 price target on the medical research company’s stock. Zacks Investment Research‘s price target would indicate a potential upside of 30.34% from the […]